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Abstract:  
Background: Most rhythmic masticatory muscle activities (RMMAs) have been 
shown to be accompanied with limb movements (LMs) in sleep bruxism (SB) patients 
during sleep.  
Objectives: To compare the relationships between RMMAs and LMs in SB patients 
and normal subjects. 
Methods: Polysomnographic recordings were performed on eight SB patients and 
nine normal subjects and the frequencies and durations of RMMAs as well as LMs 
were determined. Linear regression and correlation analysis was performed to study 
the relationship between durations of RMMAs and LMs when RMMAs occurred with 
LMs.  
Results: Most LMs in SB patients, but not in normal subjects, were accompanied 
with RMMAs. RMMAs in SB patients were more likely to be isolated, phasic or 
mixed, while RMMAs in normal subjects were more likely to be tonic. The 
frequencies of LMs, isolated RMMAs and RMMAs accompanied with LMs in SB 
patients were significantly higher than those in normal subjects. Furthermore, linear 
regression and correlation analysis showed that duration of RMMAs was significantly 
associated with that of LMs when RMMAs occurred with LMs. The duration of 
RMMAs, when accompanied with LMs, in SB patients was significantly longer than 
that in normal subjects. 
Conclusions: Close relationships between LMs and RMMAs exist in SB patients and 
normal subjects, and SB episodes may be part of cortical arousal responses and the 
increased cortical activities associated with SB episodes may not just be localized to 
the central nervous system (CNS) that controls jaw movements but may also include 
other parts of CNS that controls LMs. 
Keywords: Jaw movements; sleep bruxism; rhythmic masticatory muscle activities; 
limb movements. 
Introduction  
Sleep bruxism (SB) is a masticatory muscle activity during sleep which is rhythmic 
(phasic) or non-rhythmic (tonic) and is not a movement disorder or a sleep disorder 
for healthy individuals [1]. It affects about 8% of general population with a higher 
prevalence in children and youths [2,3]. Sleep bruxism might not only cause 
destruction to teeth but also induce temporal and masseter muscle pain, 
temporomandibular disorders, and headache although SB in some conditions (e.g. 
gastro-oesophageal reflex) might have protective effects which attribute to a decrease 
in the chance of a negative health outcome [1,4–8].  
Although some studies suggest that genetic polymorphisms, stress, anxiety, 
smoking, alcohol intake, drug abuse, sleep apnea, sleep position, and 
gastroesophageal reflux may be associated with SB [9–15], the exact 
pathophysiologic mechanisms underlying SB are still largely elusive [16–18]. The 
current treatments for SB include occlusal splints, biofeedback, kinesiotherapy, and 
repetitive transcranial magnetic stimulation, electrical stimulation as well as drug 
intake such as clonidine [19–25]. However, most of the therapies could be only used 
to protect teeth and their associated structures and none of them can effectively 
prevent the occurrence of SB without severe side effects.  
Sleep bruxism is considered to be generated in brainstem due to the imbalance of 
neurotransmitters (e.g. dopamine and GABA) and mostly happens within cortical 
arousal, which highlights changes in cortical activities around the occurrence of SB 
episodes [18,26–31]. Relevant studies showed a series of physiological changes 
before the onset of SB episodes i.e. an increase in sympathetic tone starting about 4-8 
min before the onset of SB episodes, and then an increase in power of alpha waves of 
the cortical electroencephalographic activities starting about 4 s before, followed by 
changes in heart rate, respiration and suprahyoid muscle activity [32]. There is a 
possibility that the changes in cortical activities around the occurrence of SB episodes 
may not just be localized to the part of the central nerve system that controls jaw 
movements (e.g. cortical masticatory area) but may also include the part of central 
nervous system that controls limb movements (LMs). Indeed, it has been showed that 
a majority of SB episodes (85.05%) were accompanied with LMs [33,34]. In line with 
this, it has also previously been shown that SB patients had a higher periodic leg 
movements index (PLMI) than normal subjects, and in SB patients, the number of SB 
episodes accompanied with periodic leg movements was significantly higher than that 
of the isolated SB episodes [35]. Moreover, it has previously been shown that about 
15% of patients with restless leg syndrome (RLS) also reported tooth grinding; 
conversely, about 10% of the SB patients also reported RLS-related symptoms [36]. 
Furthermore, most of SB episodes (70.52%) occurred with a companion of 
movements in both upper and lower limbs and most of LMs (70.54%) initiated prior 
to the onset of SB episodes [33].  
All of these highlight the existence of a close relationship between LMs and SB 
episodes. However, so far, analyses of the relationships between RMMAs and LMs 
were limited to the difference between their onsets. Many aspects of their 
relationships (e.g. relationship between durations of RMMAs and LMs) are still 
unknown. It is likely that durations of RMMAs and LMs are closely related in the SB 
patients since cortical arousals often occur around the occurrence of SB episodes 
[33,35]. Furthermore, RMMAs without tooth-grinding events can also be observed in 
about 60% of normal subjects during sleep [37]. It is also likely a similar relationship 
also exists between RMMAs and LMs in normal subjects given similar cortical 
arousals also often occur. Therefore, we hypothesized that the durations of RMMAs 
and LMs were closely related in both SB patients and normal subjects. The aims of 
the study were to test the hypothesis by characterizing the relationships between 
RMMAs and LMs in SB patients and normal subjects. 
  
Materials and methods 
Participants: 
As shown in Table 1, 8 SB patients (3 males and 5 females with ages of 19-24 years 
and 9 normal subjects (2 males and 7 females with ages of 19-25 years) were recruited. 
All subjects have no psychiatric, medical or sleep disorders such as sleep insomnia, 
sleep apnea, and periodic leg movement. No one used any alcohol, cigarettes, coffee, 
medications or psychostimulants during the past six months. All SB patients were first 
selected based on the following criteria: a) recent history reports from patient 
himself/herself, sleep partner, or roommates about tooth-grinding sounds at least three 
nights per week in the last six months; b) masseter hypertrophy; c) presence of tooth 
wear; d) a report of fatigue, pain, and other discomfort including transient jaw-muscle 
pain and headache in the morning. Then, diagnosis of SB was confirmed in the 
polysomnographic recordings together with audio and video monitoring according to 
the criteria established by American Association of Sleep Medicine (AASM) [38] by 
presentation of at least two SB episodes with tooth grinding sounds as well as the 
RMMA/SB index (number of RMMAs per hour of sleep) ≥ 4 and the burst index (the 
number of EMG bursts per hour of sleep) ≥ 25. The normal subjects didn’t report any 
history of tooth grinding or recent experience of sleep disorders and didn’t meet any 
diagnosis criteria above, which was also verified with two full night 
polysomnographic recordings at the sleep laboratory. 
  
Polysomnographic recordings 
Two consecutive nights of polysomnographic recordings were performed on all 
subjects in the sleep laboratory of the Jiangxi Mental Hospital. During the first night, 
all subjects were habituated to the experimental environment. The data recorded at the 
first night were only used to detect whether there were any sleep or sleep related 
disorders such as sleep apnea, restless legs syndrome, and periodic limb movements. 
The data recorded during the second night were used for analysis and presentation. 
Polysomnographic recordings of EEG (F3-A2, F4-A1,C3-A2, C4-A1, O1-A2, 
O2-A1), electrocardiographic (ECG), electrooculographic (EOG), and 
electromyographic (EMG) activities as well as recordings of respiration and 
peripheral capillary oxygen saturation were exactly the same as that described in the 
previous study [33]. Briefly, in addition to recordings from masseter muscle as in the 
routine sleep monitoring, EMG activities from myohyoid and limb muscles (bilateral 
flexor and extensor carpi radialis, gastrocnemius and tibialis anterior muscles) were 
recorded by use of cup surface electrodes. The high and low cut-off filters in the EMG 
recordings were set at 0.3 and 100 Hz, respectively, to eliminate electrical frequencies 
from cardiac, respiratory, and neural activities. Nasal airflow pressure and thermal 
sensors as well as abdominal and thoracic belts were used to record the subjects' 
respiration. A finger pulse oximeter and a position sensor were used to monitor 
peripheral capillary oxygen saturation and body position during sleep, respectively. 
Jaw movements and LMs were confirmed and nonspecific orofacial movements 
(talking, coughing, grimacing) were excluded by both audio and video recordings 
during sleep.   
All electrical signals were recorded and amplified at a sampling rate of 256 Hz, 
then stored for off-line analysis by use of the Compumedics Net Beacon Application 
(Pro Fusion PSG 3 Software, Compumedics Limited, Abbotsford, Australia) and 
Spike 2 (CED, Cambridge, UK).  
 
Data analyses and statistics: 
The sleep-related parameters shown in Table 1 were determined based on the 
criteria published by AASM [38]. According to the AASM criteria, RMMA episodes 
were classified as phasic (at least three consecutive masseter EMG bursts and each 
burst lasting for at least 0.25 s), tonic (one EMG burst lasting for longer than 2 s), and 
mixed (a mixture of phasic and tonic masseter EMG activities). The onset of RMMA 
episodes was determined when the EMG amplitude of masseter muscle exceeded two 
times the level of baseline [38]. If there was an interval of 3 s or longer between two 
RMMA bursts, they were considered as two separated RMMA episodes. The onset of 
LMs was defined when the amplitude of limb EMG was 8 μV higher than the baseline 
[38]. Besides, occurrence of LMs was considered when the duration of limb muscle 
EMG burst was longer than 0.5 s and the interval between adjacent EMG bursts was 
shorter than 5 s [38]. When there was a time overlap between masseter muscle EMG 
activity and limb muscle EMG activity, RMMA episodes and LMs were considered to 
be associated with each other.   
The statistical analyses were performed by use of GraphPad prism 7 (GraphPad 
Software, Inc., USA) and SigmaPlot 12.5 (Systat Software, Inc., USA). The 
independent sample two-tailed t-test or Mann-Whitney U test was used to analyze 
whether there were any significant differences in sleep efficiency, percentage of each 
sleep stage, RMMA/SB index, arousal index, apnea-hypopnea index, PLMI, and 
frequencies of different types of movements between SB patients and normal subjects 
wherever appropriate. The Pearson 2 tests were used to analyze whether there were 
any significant differences in distribution of types of movements (isolated RMMAs, 
isolated LMs, and RMMAs accompanied with LMs) between SB patients and normal 
subjects. The partition of 2 tests were used to test differences between any two 
different types of movements. The 2 goodness-of-fit tests were used to analyze the 
distribution of types of movements in SB patients and normal subjects. Two way 
analysis of variance (ANOVA) was used to test whether there were any significant 
differences in the durations of RMMAs and LMs between SB patients and normal 
subjects. Linear regression and correlation analyses were used to examine the 
relationship between duration of RMMA episode and its associated limb movement 
and covariance analysis was performed to compare the slopes of regression lines 
between SB patients and normal subjects. P＜0.05 was considered to be statistically 
significant. 
 
Ethical approval: 
This study was approved by the Regional Ethical Review Board at Jiangxi Mental 
Hospital (2017007) and in accordance with the ethical standards of the Declaration of 
Helsinki. Informed consent was obtained from each subject prior to participation. 
 
 
Results 
3.1 Association of RMMAs with LMs in SB patients and normal subjects. 
Three types of movements, i.e. RMMAs accompanied with LMs (movements of 
upper and/or lower limbs) (Fig.1A), isolated RMMAs (Fig.1B), and isolated LMs 
(Fig.1C) occurred in both SB patients and normal subjects. However, as shown in 
Table 2, proportions of the three types of movements in SB patients and normal 
subjects were significantly different. Moreover, 2 goodness-of-fit tests showed 
RMMAs accompanied with LMs accounted for the majority among the three types of 
movements in SB patients (P < 0.001) while isolated LMs constituted most of the 
movements in normal subjects (P < 0.001). In addition, 2 test showed there were 
significant differences in proportion of LMs with and without a companion of 
RMMAs (P < 0.001) and in proportion of RMMAs with and without a companion of 
LMs (P < 0.001) between SB patients and normal subjects (Table 2).  
 
3.2 Different types of RMMAs in SB patients and normal subjects 
The three types of RMMAs were not equally distributed in SB patients and normal 
subjects (Table 2). Pearson 2 test showed there was a significant difference in 
proportion of three types of RMMA between SB patients and normal subjects (P = 
0.002). Further partitions of 2 tests showed that there were significant differences in 
both the proportions of phasic and tonic, and the proportions of tonic and mixed types 
of RMMA between SB patients and normal subjects (P = 0.006 and P < 0.001, 
respectively; α = 0.017). 
 
3.3 Association of three types of RMMAs with LMs 
In SB patients, 64.21% phasic, 69.62% tonic, and 85.95% mixed RMMAs were 
accompanied with LMs. In contrast, in normal subjects, 86.30% phasic, 78.57% tonic, 
and 98.33% mixed RMMAs were accompanied with LMs. 2 tests showed there were 
significant differences in the proportions of phasic and mixed RMMAs accompanied 
with LMs between SB patients and normal subjects (P < 0.001 and P = 0.008, 
respectively). The proportions of phasic and mixed RMMAs accompanied with LMs 
in normal subjects were significantly higher than that in SB patients.   
 
3.4 Frequencies of LMs and RMMAs in SB patients and normal subjects 
The unpaired t-test showed there was a significant difference between SB patients 
and normal subjects in the frequency of RMMAs (RMMA events per hour) (P < 0.001, 
Table 1) and LMs (LM events per hour) (P = 0.019, Fig. 2A). In addition, there were 
also significant differences in the frequencies of RMMAs accompanied with LMs 
(unpaired t-test, P < 0.001, Fig.2B) and isolated RMMAs (P=0.038, Fig. 2C) between 
SB patients and normal subjects.  
 
3.5 Durations of RMMAs and LMs in SB patients and normal subjects 
Two way ANOVA analysis showed significant differences in durations of isolated 
RMMAs and RMMAs which were accompanied with LMs [F (1, 634) = 33.704, P < 
0.001] and between SB patients and normal subjects [F (1, 634) = 8.983, P = 0.003]. 
However, there was no significant interaction between type of subjects and duration 
of RMMAs with or without a companion of LMs [F (1, 634) = 0.270, P = 0.603]. As 
shown in Fig. 3A, post hoc Holm-Sidak tests showed that the duration of RMMAs 
which were accompanied with LMs was significantly longer than that of isolated 
RMMAs in both SB patients (P < 0.001) and normal subjects (P = 0.003). In addition, 
the duration of RMMAs which were accompanied with LMs in SB patients was 
significantly longer than that in normal subjects (P < 0.001). 
Similarly, two way ANOVA analysis showed significant difference in the durations 
of isolated LMs and LMs which were accompanied with RMMAs [F (1, 1014) = 
384.148, P < 0.001] but no significant difference between SB patients and normal 
subjects [F (1, 1014) = 0.018, P = 0.892] and no significant interactions between type 
of subjects and duration of LMs with or without a companion of RMMAs [F (1, 1014) 
= 0.120, P = 0.729]. As shown in Fig. 3B, post hoc Holm-Sidak tests showed that the 
duration of LMs which were accompanied with RMMAs was significantly longer than 
those of isolated LMs in both SB patients (P < 0.001) and normal subjects (P < 
0.001).  
 
3.6 Relationship between duration of RMMA and duration of LMs when RMMA 
were accompanied with LMs  
  There were significant correlations between the durations of RMMAs and LMs in 
both SB patients and normal subjects when RMMAs were accompanied with LMs 
(Fig. 4). As shown in Fig. 4, when the duration of LMs was considered as an 
independent variable and the duration of RMMAs as a dependent one, their 
relationship could be expressed as y =0.84*x+4.45 (R2 = 0.35, P < 0.001) in SB 
patients and y = 0.65*x+2.87 (R2 = 0.42, P < 0.001) in normal subjects. The 
covariance analysis showed that the slopes of these two regression lines were not 
significantly different (P = 0.094). 
                                                                                                                                                                                                                          
Discussion: 
Sleep bruxism is characterized by a rhythmic (phasic) or non-rhythmic (tonic) 
masticatory muscle activity during sleep [1]. Without effective treatment, SB might 
cause secondary destruction to teeth and might induce temporal and masseter muscle 
pain, temporomandibular disorders, and headache [4–7]. In the current study, we have 
found when RMMAs and LMs concurred, the durations of RMMAs and LMs were 
significantly longer than those of isolated RMMAs and LMs, respectively (Fig. 3) and 
significant correlations existed between the durations of RMMAs and LMs in both SB 
patients and controls (Fig. 4). These findings clearly indicate existence of close 
relationships between RMMAs and LMs and might help us to understand the 
pathophysiological mechanisms underlying SB.  
Sleep bruxism was once thought to be caused mainly by morphological 
abnormalities of the oromotor system and occlusal discrepancies. However, more 
recent studies have suggested that the central and autonomic nervous systems play an 
essential role in the genesis of a masticatory muscle activity during sleep that is 
rhythmic (phasic) or non-rhythmic (tonic) [1,18]. It has been shown that the 
generation of RMMAs is involved in co-activation of jaw-opening and jaw-closing 
motor neurones in the central pattern generator (CPG) for mastication, which are 
mostly inhibited during sleep, by excitatory inputs from the cortex through the 
cortico-bulbar projection and putative mechanisms that contribute to the increase in 
excitatory input to the CPG and the occurrence of SB may be related to transient 
cortical arousals and increase in sympathetic tone, which might be associated with 
changes in the influence from neurochemicals [34]. Indeed, previous studies have 
found an increase in sympathetic tone indicated by an increase in low frequency of 
heart rate variance about 4-8 minutes before the start of SB episodes, followed by an 
increase in cortical alpha and theta wave EMG activities about 4 sec before the onset 
of SB episodes and a change in respiration pattern and frequency, an increase in heart 
rate and blood pressure and jaw opening muscle activities before the onset of SB 
episodes [32,39–41]. This highlights the importance of the central and autonomic 
nervous systems in the pathophysiology of SB. Furthermore, previous studies have 
shown that a majority of episodes of SB/RMMAs were associated with cortical 
arousals and LMs and episodes of SB/RMMAs were more likely to be accompanied 
with LMs when cortical arousals occurred [33,35,42]. In the current study, we further 
showed that a positive correlation between duration of episodes of SB/RMMAs and 
LMs. These studies suggest that SB is part of an cortical arousal response and the 
increased cortical activities before and during SB episodes may not just be localized 
to the central nervous system (CNS) that controls jaw movements (eg, cortical 
masticatory area) but may also include other parts of CNS that controls LMs. 
The occurrence of SB episodes might be related to the changes in brain 
neurochemicals such as in the dopaminergic, GABAergic, serotonergic and adrenergic 
system and inhibition of the central and autonomic nervous systems by influencing of 
these neurochemicals might affect the occurrence of SB [24,31,43]. Some previous 
studies have linked dopaminergic mechanisms in the CNS to occurrence of SB and a 
possible dysfunction of central dopaminergic system has been postulated [18,40,44]. 
However, there is some inconsistence regarding the role of dopamine in the 
occurrence of SB. For example, the short-term use of L-dopa, a dopamine precursor, 
showed a decrease in frequency and duration of SB episodes in controlled 
polysomnographical studies while dopamine receptor agonists such as pramipexole 
did not show any attenuation of occurrence of SB [45–47]. Further studies are needed 
to clarify the role of dopamine in occurrence of SB. Nevertheless, the role of GABA 
in the occurrence of SB is more clear. GABA-related drugs such as diazepam, 
gabapentin, tiagabine, and gamma-hydroxybutyrate have been shown to decrease the 
occurrence of SB and these effects might be related to improvements of sleep and 
reduction of cortical arousals during sleep [48–52]. This suggests that GABA may be 
critically important to the occurrence of SB. In addition, serotonergic system might 
also be involved in the occurrence of SB. Clinical use of selective 5-HT re-uptake 
inhibitors (SSRIs), such as paroxetine, fluoxetine, fluvoxamine, and sertraline, has 
been associated with SB, which may be related to a disruption of sleep [43,53–56]. 
Indeed, other antidepressants with sedative properties like trazodone rapidly improve 
sleep and have been shown to decrease the occurrence of SB [57,58]. Moreover, 
clonidine, a selective α2 receptor agonist, has been showed to cause a significant 
decrease in the occurrence of SB [24]. This might be related to its inhibition of 
sympathetic tone preceding the onset of SB episodes, not due to inhibition of overall 
sympathetic tone since propranolol, a β adrenergic receptor antagonist does not affect 
the occurrence of SB although propranolol decreases the overall sympathetic tone 
during sleep [59]. All of these suggest increases in sympathetic activity and cortical 
arousals play an important role in the pathophysiology of SB, and inhibition of 
sympathetic or cortical activity preceding the onset of SB and cortical arousals might 
reduce the occurrence of SB. 
It is worth mentioning that there were some common features of RMMAs in SB 
patients and normal subjects. First, the increase in sympathetic activity and cortical 
arousals associated with RMMAs accompanied with LMs may last longer than that 
for generation of isolated RMMAs or isolated LMs since the durations of both LMs 
and RMMAs when they occurred together were significantly longer than that of 
isolated LMs and isolated RMMAs, respectively. Second, there were positive 
correlations between durations of RMMAs and LMs when they occurred together in 
both SB patients and normal subjects. These findings suggest genesis of RMMAs in 
both SB patients and normal controls might involve some common mechanisms.  
There were some distinct differences in the occurrence of RMMAs between SB 
patients and normal subjects, however, although the occurrence of RMMAs in normal 
subjects followed the similar pattern as in SB patients. First, RMMAs which were 
accompanied with LMs in SB patients lasted longer than those in normal subjects (Fig. 
3), which may indicate the increases in sympathetic activity associated with RMMAs 
and LMs last longer in SB patients. Second, there might exist some differences in 
frequency involved excitation of different parts of the CNS between SB patients and 
normal subjects during sleep as we have found most of the movements were RMMAs 
accompanied with LMs in SB patients while most of the movements in normal 
subjects were isolated LMs, and lower frequency of RMMAs in normal subjects as in 
the previous report [37]. Third, the occurrence of RMMAs in normal subjects might 
be more frequently accompanied with excitation of the CNS that controls LMs in 
normal subjects and occurrence of LMs in SB patients might be more frequently 
accompanied with excitation of the CNS that controls jaw movements. This was 
supported by our findings that RMMAs in normal subjects were more likely to be 
accompanied with LMs and LMs in SB patients were more likely to be accompanied 
with RMMAs (Table 2). Fourth, the frequency of LMs, especially accompanied with 
RMMAs, was significantly higher in SB patients than in normal subjects (Fig. 2), 
which is consistent with previous findings that SB patients had more periodic leg 
movements than normal subjects and further suggests occurrence of LMs in SB 
patients might be more frequently accompanied with excitation of the CNS that 
controls jaw movements, which often involved cortical arousals [33,35]. Last, the 
percentages of phasic and mixed RMMAs in SB patients were significantly higher 
than those in normal subjects. The findings may partially, at least, explain why 
RMMAs cause damages to the tooth in some SB patients, but no damage in normal 
subjects since previous studies showed that the frequency and amplitude of RMMAs 
in SB patients were significantly higher than in normal subjects and the severity of 
tooth damage was positively related to the number and duration of phasic RMMAs 
[60]. 
 
Conclusion: 
There are close relationships between LMs and RMMAs in SB patients and normal 
subjects. SB episodes may be part of cortical arousal responses and the increased 
cortical activities before and during SB episodes may not just be localized to the CNS 
that controls jaw movements (eg, cortical masticatory area) but may also include other 
parts of the CNS that controls LMs.  
 
Limitation of the study: 
The age range of the subjects was narrow and sample size of the study was 
relatively small. Moreover, no SB patients with severe symptoms were recruited. 
Further study with more polysomnographic recordings on large number of subjects is 
required. In addition, the data used for presentation in the current study were collected 
only from one night recordings and polysomnographic recordings from more nights 
might be needed as RMMAs/SB in SB patients /normal subjects might vary from 
night to night.  
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Table 1. Comparisons of age and general sleep variables between SB patients and 
normal subjects. 
Variable Normal subjects SB patients 
Age 21.44 (1.88) 21.75 (1.75) 
Total sleep time (min) 405.56 (29.67) 415.13 (72.21) 
Sleep efficiency (%) 93.15 (4.06) 95.77 (1.81) 
Sleep stage (%) 
  N1  
 
11.78 (5.05) 
 
8.53 (2.65) 
  N2  42.78 (7.30) 39.84 (4.52) 
  N3  22.54 (5.93) 29.26 (7.30) 
  REM  22.90 (3.77) 22.38 (5.63) 
RMMA/SB index (events/h)  2.94 (1.73-4.99) 7.50 (6.19-13.26) *** 
Arousal index (events/h)  3.30 (2.46-8.96) 7.25 (6.00-10.84) **  
Apnea-Hypopnea index (events/h) 0.20 (0.00-0.70) 0.30 (0.00-1.00) 
PLMI (events/h) 0.52 (0.00-3.05) 0.93 (0.00-5.42) 
Mean (standard deviation) for variables with normal distribution.  
Median (min-max) for variables with non-normal distribution. PLMI: periodic leg 
movement index. 
**P < 0.01; ***P < 0.001 
 
 
 
Table 2. The comparisons of RMMAs and LMs in SB patients and normal subjects. 
 
 
 
Figure legends: 
 
 
SB 
patients 
Normal 
subjects 
P value of 
2 tests 
P value of 
partition of 2 tests 
Movements (n) 710 455   
A: RMMAs with LMs  47.32% 36.48% 
＜0.001 
< 0.001 (A : B) 
B: Isolated RMMAs 16.62% 5.06% < 0.001 (B : C) 
C: Isolated LMs 36.06% 58.46% < 0.001 (A : C) 
     
LMs (n) 592 432   
  A: Isolated 43.24% 61.57% 
＜0.001 
 
  B: With RMMAs 56.76% 38.43%  
     
RMMAs (n) 454 189   
A: Isolated 25.99% 12.17% 
＜0.001 
 
B: With LMs 74.01% 87.83%  
     
RMMAs (n) 454 189   
A: Phasic 41.85% 38.62% 
0.002 
0.006 (A : B) 
＜0.001 (B : C) 
B: Tonic 17.40% 29.63% 
C: Mixed 40.75% 31.75% 
Fig. 1. An example of RMMA accompanied with LM (A), isolated RMMA (B), and 
isolated LM (C) during sleep. MASS: masseter muscle; MH: myohyoid muscle; RUE: 
right extensor carpi radialis; RUF: right flexor carpi radialis; LUE: left extensor carpi 
radialis; LUF: left flexor carpi radialis; RLE: right tibialis anterior muscle; RLF: right 
gastrocnemius; LLE: left tibialis anterior muscle; LLF: left gastrocnemius. Horizontal 
bar: 5 s; Vertical bar:100 μV. 
 
Fig. 2. Comparisons of the frequencies of LMs (A) and RMMAs accompanied with 
LMs (B), and isolated RMMAs (C) in SB patients and normal subjects. Error bars 
represent one standard deviation. *P < 0.05; ***P < 0.001.  
 
Fig. 3. Comparisons of the durations of RMMAs (A) and LMs (B) in SB patients and 
normal subjects. Error bars represent one standard deviation. **P < 0.01; ***P < 
0.001. 
 
Fig. 4. Relationships between durations of RMMAs and LMs in SB patients and 
normal subjects when RMMAs were accompanied with LMs. 
  
  
 
  
 
  
 
